Skip to main content
. 2019 Aug 2;3(10):e10211. doi: 10.1002/jbm4.10211

Table 2.

Grade of New Clinical VFx in the Romosozumab‐ and Placebo‐Treated Groups

Clinical VFx
Romosozumab 210 mg QM Placebo
Grade a N = 3 N = 17
1 0 3 (17.65)
2 2 (66.67) 7 (41.18)
3 1 (33.33) 7 (41.18)

Values shown are n (%).

QM = monthly; VFx = vertebral fracture.

a

Grade of clinical VFx was assessed according to the method of Genant.13